Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

AIT-082 enters clinic

March 7, 1997

Teva receives tentative approval for ketorolac tromethamine

March 7, 1997

Cypros receives SBIR grant

March 6, 1997

Neuroimmunophilin ligand shows promise for Parkinson's disease

March 6, 1997

Glaxo Wellcome evaluates melatonin agonist

March 6, 1997

Abbott describes AK inhibitor with anticonvulsant/neuroprotective effects

March 6, 1997

Pharmacia & Upjohn claims antimigraine agents

March 6, 1997

RAS inhibitors reduce mortality in a model of cerebral ischemia

March 5, 1997

Biogen signs distribution agreement with Genesis Pharma

March 5, 1997

Knoll reveals compounds with 5-HT1A receptor affinity

March 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...